Bright Minds Biosciences (DRUG) Operating Expenses (2020 - 2026)
Bright Minds Biosciences (DRUG) posted Operating Expenses of -$9.6 million for Q1 2026, down 59.5% on a QoQ basis from -$6.0 million in Q4 2025, and down 508.37% year-over-year from $2.3 million in Q1 2025.
Bright Minds Biosciences (DRUG) Operating Expenses (2020 - 2026) Analysis & Trends
Bright Minds Biosciences' Operating Expenses history runs 7 years deep, the most recent figure standing at -$9.6 million for Q1 2026.
- Quarterly Operating Expenses fell 508.37% year-over-year to -$9.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.1 million (down 199.7% YoY) and the FY2025 annual result came in at $10.0 million, up 381.22% from the prior year.
- Operating Expenses was -$9.6 million for Q1 2026 at Bright Minds Biosciences, down from -$6.0 million in the prior quarter.
- Across five years, Operating Expenses topped out at $16.8 million in Q3 2025 and bottomed at -$9.6 million in Q1 2026.
- A 5-year average of $755460.1 and a median of $951047.2 in 2023 frame the typical range for Operating Expenses.
- Peak annual rise in Operating Expenses reached 2842.82% in 2025, while the deepest fall reached 18642.06% in 2025.
- Bright Minds Biosciences' Operating Expenses stood at $1.1 million in 2022, then slipped by 15.2% to $951047.2 in 2023, then sank by 96.59% to $32422.2 in 2024, then sank by 18642.06% to -$6.0 million in 2025, then slumped by 59.5% to -$9.6 million in 2026.
- Business Quant data shows DRUG's Operating Expenses at -$9.6 million in Q1 2026, -$6.0 million in Q4 2025, and $16.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.10 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.78 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 2.89 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 445.22 Mn |
| 10 | Bright Minds Biosciences | 498.53 Mn | 498.53 Mn | - | -9.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.59 Mn |
| Dec 31, 2025 | -6.01 Mn |
| Sep 30, 2025 | 16.81 Mn |
| Jun 30, 2025 | -4.31 Mn |
| Mar 31, 2025 | 2.35 Mn |
| Dec 31, 2024 | 32,422.24 |
| Sep 30, 2024 | 571,377.01 |
| Jun 30, 2024 | 157,133.80 |
| Mar 31, 2024 | 1.25 Mn |
| Dec 31, 2023 | 951,047.22 |
| Sep 30, 2023 | 779,792.73 |
| Jun 30, 2023 | 873,040.99 |
| Mar 31, 2023 | 1.14 Mn |
| Dec 31, 2022 | 1.12 Mn |
| Sep 30, 2022 | 2.03 Mn |
| Jun 30, 2022 | 1.68 Mn |
| Mar 31, 2022 | 3.01 Mn |
| Dec 31, 2021 | 3.22 Mn |
| Sep 30, 2021 | 1.83 Mn |
| Jun 30, 2021 | 2.25 Mn |